Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
Notified -
Globe Newswire27-01-2025, 18:00
Introducing the Cavli C17QS: Harnessing the power of Low Power Cat 1bis technology with integrated SDK 13-06-2024, 14:59